1. Home
  2. IMMP vs JMSB Comparison

IMMP vs JMSB Comparison

Compare IMMP & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • JMSB
  • Stock Information
  • Founded
  • IMMP 1987
  • JMSB 2005
  • Country
  • IMMP Australia
  • JMSB United States
  • Employees
  • IMMP N/A
  • JMSB N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • JMSB Major Banks
  • Sector
  • IMMP Health Care
  • JMSB Finance
  • Exchange
  • IMMP Nasdaq
  • JMSB Nasdaq
  • Market Cap
  • IMMP 251.8M
  • JMSB 246.7M
  • IPO Year
  • IMMP N/A
  • JMSB N/A
  • Fundamental
  • Price
  • IMMP $1.57
  • JMSB $18.62
  • Analyst Decision
  • IMMP Buy
  • JMSB
  • Analyst Count
  • IMMP 1
  • JMSB 0
  • Target Price
  • IMMP $7.00
  • JMSB N/A
  • AVG Volume (30 Days)
  • IMMP 111.5K
  • JMSB 16.3K
  • Earning Date
  • IMMP 02-27-2025
  • JMSB 07-23-2025
  • Dividend Yield
  • IMMP N/A
  • JMSB 1.63%
  • EPS Growth
  • IMMP N/A
  • JMSB 475.76
  • EPS
  • IMMP N/A
  • JMSB 1.24
  • Revenue
  • IMMP $3,019,249.00
  • JMSB $54,782,000.00
  • Revenue This Year
  • IMMP $50.37
  • JMSB N/A
  • Revenue Next Year
  • IMMP N/A
  • JMSB N/A
  • P/E Ratio
  • IMMP N/A
  • JMSB $14.85
  • Revenue Growth
  • IMMP 24.11
  • JMSB 50.81
  • 52 Week Low
  • IMMP $1.32
  • JMSB $13.81
  • 52 Week High
  • IMMP $2.80
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 36.75
  • JMSB 66.05
  • Support Level
  • IMMP $1.51
  • JMSB $17.30
  • Resistance Level
  • IMMP $1.63
  • JMSB $18.89
  • Average True Range (ATR)
  • IMMP 0.07
  • JMSB 0.39
  • MACD
  • IMMP -0.03
  • JMSB 0.10
  • Stochastic Oscillator
  • IMMP 14.34
  • JMSB 89.69

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: